Skip to content

REGENEREX PHARMA, INC.: 10-Q/A filed 2022-02-03

What REGENEREX PHARMA, INC. reported in its quarterly report amendment filed 2022-02-03 (fiscal Q3 2021): 28 published measures, 75 facts as tagged in accession 0001472375-22-000015.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-Q/A (quarterly report amendment)
Filed
2022-02-03
Fiscal period
fiscal Q3 2021
Accession
0001472375-22-000015 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All REGENEREX PHARMA, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-12-3111,415USD
At 2021-03-3110,470USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-12-31948,583USD
At 2021-03-31845,496USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-12-31-937,168USD
At 2021-09-30-902,734USD
At 2021-03-31-835,026USD
At 2020-12-31-550,546USD
At 2020-09-30-516,863USD
At 2020-03-31-481,274USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-12-312,789USD
At 2021-03-316,902USD
At 2020-12-311,721USD
At 2020-03-315,460USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-10-01 to 2021-12-31-79,434USD92
2021-04-01 to 2021-12-31-147,142USD275
2021-04-01 to 2021-09-30-67,708USD183
2020-10-01 to 2020-12-31-33,683USD92
2020-04-01 to 2020-12-31-69,272USD275
2020-04-01 to 2020-09-30-35,589USD183

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-04-01 to 2021-12-31-63,050USD275
2020-04-01 to 2020-12-31-37,552USD275

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2020-10-01 to 2020-12-31181USD92
2020-04-01 to 2020-12-31378USD275

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-04-01 to 2021-12-3167,537USD275
2020-04-01 to 2020-12-3133,813USD275

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-04-01 to 2021-12-31-8,600USD275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-12-31-1,886,244USD
At 2021-03-31-1,739,102USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2021-04-01 to 2021-12-3145,000USD275

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-10-01 to 2021-12-31-62,997USD92
2021-04-01 to 2021-12-31-103,495USD275
2020-10-01 to 2020-12-31-14,252USD92
2020-04-01 to 2020-12-31-36,313USD275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-12-312,789USD
At 2021-03-318,115USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2021-10-01 to 2021-12-3114,548USD92
2021-04-01 to 2021-12-3144,130USD275
2020-10-01 to 2020-12-3111,203USD92
2020-04-01 to 2020-12-3131,335USD275

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-12-31598,829USD
At 2021-03-31621,319USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2021-12-3147,813USD
At 2021-03-3148,038USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2021-12-318,626USD
At 2021-03-312,355USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-10-01 to 2021-12-3162,997USD92
2021-04-01 to 2021-12-31103,495USD275
2020-10-01 to 2020-12-3114,069USD92
2020-04-01 to 2020-12-3136,285USD275

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2020-10-01 to 2020-12-31-183USD92
2020-04-01 to 2020-12-31-28USD275

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2020-10-01 to 2020-12-31364USD92
2020-04-01 to 2020-12-31406USD275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-12-31277,112,660shares
At 2021-03-31127,112,660shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2021-12-31671,963USD
At 2021-03-31776,963USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2021-12-3179,524USD
At 2021-03-3171,003USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2021-10-01 to 2021-12-3162,385USD92
2021-04-01 to 2021-12-31100,192USD275
2020-10-01 to 2020-12-3112,103USD92
2020-04-01 to 2020-12-3133,229USD275

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2021-04-01 to 2021-12-312,329USD275
2020-04-01 to 2020-12-314,167USD275

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2021-10-01 to 2021-12-311,016USD92
2021-01-01 to 2021-12-31504USD365
2020-10-01 to 2020-12-312,329USD92
2020-01-01 to 2020-12-314,167USD366

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2021-10-01 to 2021-12-31-16,437USD92
2021-04-01 to 2021-12-31-43,647USD275
2020-10-01 to 2020-12-31-19,431USD92
2020-04-01 to 2020-12-31-32,959USD275

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2020-04-01 to 2020-12-31406USD275

Inspect the source

Entity
REGENEREX PHARMA, INC. / CIK 0001357878
Captured
2026-09-21T17:18:44.819Z
SEC response SHA-256
213194c506fa9441e1992f90b01cc25fc346a1dd3e1f77e4d19752e41180a033

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001357878.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))